Pharmaceutical laboratory and GMP production line
Subsidiary

Local Innovation, Global Standards.

Building bridges between African healthcare systems and global pharmaceutical innovation.

0
GMP partners

Local & regional manufacturers*

0
programs

Licensing & co-development MoUs*

0
months

Avg. tech transfer to first batch*

0
filings

Regulatory submissions in pipeline*

About Dadaba Pharma Ltd

Innovating healthcare access in Africa through licensing, tech transfer and local GMP production.

Who we are

Dadaba Pharma Ltd is the biotechnology and pharmaceutical development subsidiary of Dadaba Group Companies Ltd.

We focus on licensing expired or transferable European IPs, developing local manufacturing partnerships, and facilitating regulatory pathways for African production.

Mission & Vision

Vision: To position Africa as a hub for accessible and affordable pharmaceutical innovation.

Mission: To bridge scientific discovery and African production capacity.

How we work

  • Global originators & dossier holders engaged via structured licensing
  • Local GMP partners onboarded for technology transfer
  • Regulatory strategy across FDA, GSA & WHO PQ where applicable
  • Cold-chain & QA logistics via Dadaba Smart Cold-Hub

Core activities

End-to-end pathway from IP to local manufacturing and market access.

IP licensing agreements
IP

Licensing of expired IPs

Formulations and dossiers sourced from European originators and global partners.

Formulation and R&D
R&D

R&D partnerships

Co-development with universities, CROs and reference labs.

GMP manufacturing line
GMP

Local manufacturing

Tech transfer, validation batches and scale-up with audited GMP facilities.

Regulatory documents
Regulatory

Regulatory support

FDA, GSA and WHO PQ documentation and submission management.

Cold chain logistics
Logistics

Cold-chain logistics

GDP-aligned storage and distribution via Dadaba Smart Cold-Hub.

Pharmacovigilance
Quality

Quality & PV

QMS, batch release support, stability, and pharmacovigilance setup.

Current program lanes

Non-exhaustive focus areas — open to collaboration and in-licensing.

Essential generics

Orals and injectables on national EMLs with supply gaps.

AntimicrobialsCVSDiabetes

Biologics pathways

Fill-finish and stability programs with global partners.

Vaccines (fill-finish)Cold-chain

Diagnostics & devices

Regulatory support for POCT and essential devices.

IVDCalibration

Note: Program details are indicative and subject to regulatory review and partner due diligence.

Regulatory, quality & compliance

Built on global standards adapted to local requirements.

QA

Quality systems

QMS documentation, validation master plans, and change control.

Docs

Dossier management

CTD/eCTD, BE/BA studies, stability protocols, and submission tracking.

Gov

Inspections & audits

Pre-inspection readiness for FDA/GSA and support for WHO PQ audits.

Medical/Legal disclaimer: This page does not promote any specific medicinal product. All collaborations follow applicable laws and regulator guidance.

Why choose Dadaba Pharma

De-risked licensing, credible GMP pathways, and integrated logistics.

Speed

Faster time-to-market

Standardized tech-transfer playbooks and partner bench.

Network

Global & local

Originators abroad, audited plants at home — end-to-end reach.

Reg

Regulatory rigor

Experienced RA/QA teams and external advisors.

Logistics

Cold-chain integrated

GDP distribution via Dadaba Smart Cold-Hub & Logistics.

ESG

Access & affordability

Localized value chains and workforce development.

Partnerships

Where scientific discovery meets local production capacity.

Who we partner with

  • Originators & dossier holders (EU & global)
  • Universities, CROs and reference laboratories
  • Local GMP manufacturers and CMOs
  • Donors, multilaterals and procurement agencies

Dadaba Group synergy

  • Smart Cold-Hub & Logistics — cold-chain and QA distribution
  • Energy & Utilities — solar for sustainable plants
  • Fintech — digital trade & payments
  • Foundation — training & workforce pipelines

Submit a molecule / RFP

Share a concise brief — we’ll revert with a data-room request and next steps.

What to expect

  • NDA & data-room invite (if aligned)
  • Technical & regulatory gap assessment
  • Site audit or virtual tour (for GMP partners)
  • Term sheet & implementation plan

Documentation

Be ready with CTD/eCTD, CoA, stability data, and GMP/QMS evidence where available.

SELECTED PARTNERS & INITIATIVES
Partner 1
Partner 2
Partner 3
COP28
GRO
AMPATH